Author:
Wohl David,Clarke Amanda,Maggiolo Franco,Garner Will,Laouri Marianne,Martin Hal,Quirk Erin
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Gunthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel. JAMA. 2016;316:191–210.
2. European AIDS Clinical Society. Guidelines. Version 9.0. October 2017. Brussels: European AIDS Clinical Society, 2017. www.eacsociety.org/files/guidelines_9.0-english.pdf . Accessed 30 May 2018.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: U. S. Department of Health and Human Services, Washington D.C., USA. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf . Last Updated 27 March 2018. Accessed 30 May 2018.
4. Blanco J, Montaner JSG, Matconi VC, et al. Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenpfovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy. AIDS. 2015;28:2531–9.
5. Elliot E, Chirwa M, Boffito M. How recent findings on the pharmacokinetics and pharmacodynamics of integrase inhibitors can inform clinical use. Curr Opin Infect Dis. 2017;30:58–73.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献